Dyslipidemia (abnormal blood lipid levels) is rapidly becoming a global epidemic. According to a 2025 article published in the Journal of Health, Population and Nutrition, the global prevalence among adults stands at 28.8% for hypertriglyceridemia, 24.1% for hypercholesterolemia, 38.4% for low HDL (good) cholesterol, and 18.93% for high LDL (bad) cholesterol.
“Normal” Cholesterol is a Relative Concept
The idea of “meeting the target” for lipid test results is not one-size-fits-all. Every individual’s cardiovascular risk level is different, meaning their lipid control goals must also differ.
The 2025 updated guidelines for the management of dyslipidemia in adults by the American Association of Clinical Endocrinology (AACE) clearly state:
- For general high-risk patients: LDL cholesterol should be kept below 1.8 mmol/L.
- For very high-risk patients: LDL cholesterol should be kept below 1.4 mmol/L.
- For extreme-risk patients: The guidelines suggest maintaining LDL cholesterol below 1.0 mmol/L.
How High Lipids Damage Your Arteries
The core damage caused by dyslipidemia to blood vessels is the formation of atherosclerotic plaques. When LDL cholesterol levels are too high, cholesterol easily deposits within the artery walls. This triggers an inflammatory response, gradually leading to the formation of plaque.
Can Plaque Disappear Once Lipids Are Controlled?
When blood lipid levels are successfully controlled through medication or lifestyle interventions, plaques can shrink or even regress—but this requires driving LDL cholesterol down to a significantly low level.
A 2025 analysis published in JACC: Asia found that when LDL cholesterol is controlled below 1.4 mmol/L, coronary plaque volume can be reduced by an average of 1.56%. Simultaneously, intensive lipid-lowering therapies can increase the fibrous cap thickness by 66.90 μm, making the plaque much more stable and less prone to rupturing. Research also indicates that moderate-to-high intensity statins combined with ezetimibe or PCSK9 inhibitors offer the most effective results for promoting plaque regression.
However, not all plaques can “disappear.” Different types of plaques respond differently to lipid-lowering treatments. Once calcified plaques form, they are irreversible. Soft plaques, on the other hand, may shrink with long-term treatment. Even when LDL cholesterol is reduced to an ideal level, plaque regression is not immediate. It often takes 5 to 10 years for a plaque to form, and its regression requires equal time and patience. Studies show that when LDL cholesterol is consistently kept below 1.8 mmol/L, approximately 60% of soft plaques will show signs of reversal after 2 to 4 years.
Furthermore, even if lipid targets are met, the restorative capacity of the vascular endothelium (the inner lining of blood vessels) is impacted by multiple factors like age, blood sugar, and blood pressure. Persistent chronic low-grade inflammation can also blunt the benefits of lipid-lowering therapies. This explains why some patients still face cardiovascular risks even with a “normal” lipid profile.
The “Three Commitments” for Long-Term Vascular Health
For the vast majority of people managing high cholesterol, getting lipid markers back to normal is only the first step. Long-term vascular health management requires adhering to three core commitments:
- Commit to Long-Term Control: Based on your personal risk level, continuously maintain lipid levels below your specific target, rather than settling for the “normal” range printed on a standard lab report.
- Commit to Comprehensive Management: Reaching lipid targets is just the foundation. Blood pressure, blood sugar, weight, and systemic inflammation are equally crucial factors affecting plaque stability and require simultaneous attention.
- Commit to Regular Monitoring: Do not rely solely on blood tests. Utilize imaging techniques, such as carotid ultrasounds, to actively track changes in arterial plaque buildup.
Natural Herbal Support for Cardiovascular Maintenance
In addition to medical and lifestyle interventions, supplementing with certain natural plant compounds can provide extra support for vascular health. For example, Reishi polysaccharides, the primary active ingredients in the traditional herb Reishi mushroom (Ganoderma lucidum), possess strong anti-inflammatory and antioxidant properties. Research shows they can help regulate the gut microbiome and improve both blood sugar and lipid profiles.
For individuals requiring long-term lipid management, BISPIT Blood Lipid Lowering Tablets offer a scientifically formulated blend of natural plant ingredients, including nattokinase, red yeast rice, tea polyphenols, hawthorn flavonoids, pueraria (kudzu) flavonoids, and Reishi polysaccharides. Through multi-target synergy, this formula helps lower total cholesterol and triglycerides while elevating HDL cholesterol, comprehensively improving the lipid profile. Ingredients like Reishi polysaccharides provide deeper vascular support through their anti-inflammatory and antioxidant potential, actively improving endothelial function.
Complementing this, the BISPIT Reishi Tonic Liquid utilizes a dual-patented fermentation process. Through multi-strain and multi-stage continuous directional fermentation technology, it maximizes the release of active compounds from rare herbs like Reishi, Purple Reishi, and Red Reishi. Blended with ten botanical extracts—including Black Wolfberry, Golden Tremella, and Maitake—it provides long-lasting nourishment for blood vessels, boosts the immune system, and offers gentle, sustained support for overall cardiovascular and cerebrovascular health.
Conclusion Having normal lipid markers does not automatically mean your blood vessels have fully healed. Keeping your lipids at a safe level simply creates the necessary environment for vascular recovery. Only through long-term, comprehensive, and persistent management can you truly restore and maintain a stable and healthy cardiovascular system.